There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Intuitive Surgical (ISRG – Research Report) and Revolution Medicines (RVMD – Research Report) with bullish sentiments.
Intuitive Surgical (ISRG)
Stifel Nicolaus analyst Rick Wise maintained a Buy rating on Intuitive Surgical today and set a price target of $430.00. The company’s shares closed last Thursday at $372.63.
According to TipRanks.com, Wise is a 4-star analyst with an average return of
Currently, the analyst consensus on Intuitive Surgical is a Moderate Buy with an average price target of $423.00, representing a 13.5% upside. In a report issued on April 8, Wells Fargo also maintained a Buy rating on the stock with a $416.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Revolution Medicines (RVMD)
Stifel Nicolaus analyst Benjamin Burnett maintained a Buy rating on Revolution Medicines today and set a price target of $43.00. The company’s shares closed last Thursday at $35.83, close to its 52-week high of $38.73.
According to TipRanks.com, Burnett is ranked 0 out of 5 stars with an average return of
Currently, the analyst consensus on Revolution Medicines is a Strong Buy with an average price target of $42.44, implying a 15.8% upside from current levels. In a report issued on April 8, Needham also maintained a Buy rating on the stock with a $36.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ISRG:
- Intuitive Surgical Stock (NASDAQ:ISRG) Gains after Q1 Earnings Beat
- Options Volatility and Implied Earnings Moves Today, April 18, 2024
- ISRG Upcoming Earnings Report: What to Expect?
- Intuitive Surgical added to ‘US 1 List’ at BofA, Lowe’s removed
- Intuitive Surgical price target raised to $430 from $420 at Stifel
